4.5 Review

A novel complement-metabolism-inflammasome axis as a key regulator of immune cell effector function

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 46, Issue 7, Pages 1563-1573

Publisher

WILEY
DOI: 10.1002/eji.201546131

Keywords

Complement; Metabolism; NLRP3 inflammasome

Categories

Funding

  1. MRC Centre [MR/J006742/1]
  2. EU
  3. Wellcome Trust Investigator Award
  4. King's Bioscience Institute at King's College London
  5. National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London
  6. Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH
  7. intramural research program of NIAID, NIH
  8. Medical Research Council [MR/J006742/1] Funding Source: researchfish

Ask authors/readers for more resources

The inflammasomes are intracellular multiprotein complexes that induce and regulate the generation of the key pro-inflammatory cytokines IL-1 beta and IL-18 in response to infectious microbes and cellular stress. The activation of inflammasomes involves several upstream signals including classic pattern or danger recognition systems such as the TLRs. Recently, however, the activation of complement receptors, such as the anaphylatoxin C3a and C5a receptors and the complement regulator CD46, in conjunction with the sensing of cell metabolic changes, for instance increased amino acid influx and glycolysis (via mTORC1), have emerged as additional critical activators of the inflammasome. This review summarizes recent advances in our knowledge about complement-mediated inflammasome activation, with a specific focus on a novel complement - metabolism - NLRP3 inflammasome axis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available